Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Company profile
Ticker
TMO
Exchange
Website
CEO
Marc Casper
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
THERMO ELECTRON CORP
SEC CIK
Corporate docs
Subsidiaries
0972792 B.C. LTD • 236 Perinton Parkway, LLC • 27 Forge Parkway LLC • Abgene Inc. • Abgene Limited • ABII 2 Limited • ACI Holdings Inc. • Acoustic Cytometry Systems, Inc. • AcroMetrix LLC • Acros Organics BV ...
IRS number
42209186
TMO stock data
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
6 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
1 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
20 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
31 Jan 24
8-K
Thermo Fisher Scientific Reports Fourth Quarter 2023 Results
31 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
4 Jan 24
SC TO-T/A
Third party tender offer statement (amended)
22 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
15 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
12 Dec 23
Transcripts
TMO
Earnings call transcript
2023 Q4
31 Jan 24
TMO
Earnings call transcript
2023 Q3
25 Oct 23
TMO
Earnings call transcript
2023 Q2
26 Jul 23
TMO
Earnings call transcript
2023 Q2
26 Jul 23
TMO
Earnings call transcript
2023 Q1
26 Apr 23
TMO
Earnings call transcript
2022 Q4
1 Feb 23
TMO
Earnings call transcript
2022 Q3
26 Oct 22
TMO
Earnings call transcript
2022 Q2
28 Jul 22
TMO
Earnings call transcript
2022 Q1
28 Apr 22
TMO
Earnings call transcript
2021 Q4
2 Feb 22
Latest ownership filings
4
Science 37 Holdings, Inc.
14 Mar 24
4
Science 37 Holdings, Inc.
14 Mar 24
3/A
Science 37 Holdings, Inc.
14 Mar 24
SC 13D/A
Science 37 Holdings, Inc.
14 Mar 24
4
MARC N CASPER
14 Mar 24
4
MARC N CASPER
13 Mar 24
4
Lisa P. Britt
13 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
144
Notice of proposed sale of securities
12 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jul 23 | Apr 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
70.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2064 |
Opened positions | 227 |
Closed positions | 470 |
Increased positions | 733 |
Reduced positions | 821 |
13F shares | Current |
---|---|
Total value | 122.98 tn |
Total shares | 268.08 mm |
Total puts | 689.38 k |
Total calls | 557.00 k |
Total put/call ratio | 1.2 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 32.98 mm | $17.50 tn |
STT State Street | 16.48 mm | $8.75 tn |
MS Morgan Stanley | 12.55 mm | $6.66 tn |
Whalerock Point Partners | 12.44 mm | $6.60 bn |
Capital World Investors | 12.26 mm | $6.51 tn |
T. Rowe Price | 9.90 mm | $5.25 bn |
Capital Research Global Investors | 7.99 mm | $4.24 tn |
FMR | 7.85 mm | $4.17 tn |
Massachusetts Financial Services | 4.18 mm | $2.22 tn |
NTRS Northern Trust | 3.79 mm | $2.01 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 597.99 | 300 | 179.40 k | 123,816.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 597.39 | 1,073 | 641.00 k | 124,116.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 596.49 | 1,662 | 991.37 k | 125,189.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 595.06 | 900 | 535.55 k | 126,851.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 594.02 | 2,172 | 1.29 mm | 127,751.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 593.01 | 3,593 | 2.13 mm | 129,923.462 |
13 Mar 24 | Casper Marc N | Common Stock | Sell | Dispose S | No | Yes | 591.82 | 300 | 177.55 k | 133,516.462 |
13 Mar 24 | Casper Marc N | Common Stock | Option exercise | Acquire M | No | No | 190.59 | 10,000 | 1.91 mm | 133,816.462 |
13 Mar 24 | Casper Marc N | Stock Option Common Stock | Option exercise | Dispose M | No | No | 190.59 | 10,000 | 1.91 mm | 56,300 |
12 Mar 24 | Thermo Fisher Scientific | Common Stock | Dispose U | Yes | No | 5.75 | 868,990 | 5.00 mm | 0 |
News
4 Analysts Assess Thermo Fisher Scientific: What You Need To Know
18 Mar 24
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
14 Mar 24
Top 7 Biotech Stock Winners As Weight Loss Drug Battle Escalates: Goldman Sachs Names Best Picks
13 Mar 24
10 Health Care Stocks Whale Activity In Today's Session
6 Mar 24
Samsara, Thermo Fisher Scientific And More: CNBC's 'Final Trades'
1 Mar 24
Press releases
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
1 Mar 24
Thermo Fisher Scientific Increases Quarterly Dividend
21 Feb 24
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
31 Jan 24
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
30 Jan 24
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
4 Jan 24